UBS GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.27 CHF | -3.31% |
|
-4.41% | -7.01% |
| Apr. 30 | Swiss Stocks Retreat Amid Economic Data Focus in Europe | MT |
| Apr. 30 | Swiss Regulator Flags Potential Probe into UBS Group's Market Boost | MT |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company appears to be poorly valued given its net asset value.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With a 2024 P/E ratio at 32.44 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -7.01% | 84.95B | C+ | ||
| -7.42% | 112B | A- | ||
| +16.30% | 61.67B | C | ||
| +6.06% | 60.84B | - | B+ | |
| +8.47% | 42.24B | C+ | ||
| +8.85% | 41.01B | A- | ||
| +17.51% | 34.74B | A- | ||
| +2.42% | 24.47B | B | ||
| -5.62% | 21.86B | A- | ||
| +1.50% | 18.61B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- UBSG Stock
- Ratings UBS Group AG
